ABSTRACT
Although aromatic formylation reactions are highly valuable from a synthetic perspective, a biocatalytic version has not yet been reported. Here, the cofactor‐independent multimeric three‐component acyltransferase from Chromobacterium sphagni (CsATase) was identified to enable the nonnatural promiscuous regioselective C‐formylation of polyphenolic substrates, especially resorcinol derivatives, and thus extending the reaction scope of acyltransferases. Formylation of 4‐ and 5‐substituted resorcinol derivatives gave access to regioselectively mono‐formylated products with up to 99% conversion and up to 74% isolated yield. Formylation of phloroglucinol led to the di‐formylated product with 99% conversion, outperforming chemical methods. Structural analysis of CsATase by X‐ray crystallography provided insights into its active site.
Keywords: acyltransferases, biocatalysis, biocatalytic formylation, resorcinol derivatives, X‐ray structure elucidation
An acyltransferase from Chromobacterium sphagni (CsATase) was identified that catalyzes the regioselective formylation of resorcinol substrates. The formylation of substituted resorcinol derivatives yielded mono‐formylated products with up to 99% conversion and up to 74% isolated yield. The structure of CsATase was elucidated by X‐ray crystallography, providing insight into its active site.

1. Introduction
Aromatic aldehydes are ubiquitous targets and intermediates in organic synthesis due to the versatility of the formyl group, which can be easily transformed into a variety of functional groups, including alcohols, carboxylic acids, and esters [1, 2, 3, 4, 5]. Although several methods have been developed for the formylation of aromatic compounds [6], the formylation of phenols through C─C bond‐forming reactions has remained a significant challenge throughout the history of organic chemistry [7]. Classical methods involve direct formylation reagents that introduce the formyl group in a single step. For instance, the Gattermann reaction [8, 9, 10] was subsequently simplified by Adams, who replaced the hazardous combination of HCN and ZnCl2 with the more stable and safer Zn(CN)2 (Scheme 1A) [11]. Around the same time, Reimer and Tiemann demonstrated that phenols can be formylated using chloroform in an aqueous alkali medium (Scheme 1B) [12, 13, 14]. The formylation of a wide range of substrates, particularly electron‐rich aromatics, can be efficiently achieved using the adduct formed between N,N‐dimethylformamide [15] (DMF) and phosphoryl chloride (POCl3), in a process known as the Vilsmeier–Haack reaction (Scheme 1C) [16, 17]. Other methods involve multi‐step C─C bond‐forming processes, in which functionalized intermediates are generated and subsequently oxidized to yield the target aldehydes. Prominent examples of this approach include the Mannich‐type Duff formylation [18, 19] and the Casiraghi approach utilizing iminium intermediates to achieve formylation through the reaction between phenols and paraformaldehyde [20, 21]. Other formylating agents have been developed as well, such as formyl fluoride [22, 23], dichloromethyl methyl ether [24, 25], formamide derivatives in the presence of Lewis acids [26], and organo‐metallic approaches, such as utilizing magnesium phenoxides and formaldehyde in the Casnati–Skattebøl reaction [21]. In contrast to these many chemical methods, a biocatalytic method [27, 28, 29, 30, 31, 32, 33, 34] for the C‐formylation of phenols via C─C bond formation has remained elusive. Nevertheless, significant advances have been made in biocatalytic C─C bond‐forming reactions [35, 36, 37, 38, 39, 40, 41, 42, 43], employing both wild‐type enzymes and engineered variants. These include classical transformations such as aldol reactions [44, 45, 46, 47, 48, 49, 50, 51], acyloin condensations [52, 53], carboligation [54, 55], and cyanohydrin formations [56, 57, 58], as well as transformations such as alkylation [59, 60, 61], acylation [62, 63, 64], oxidative C–C coupling [65, 66, 67, 68], cyclization [69, 70], and carbene transfer [71, 72, 73, 74, 75].
SCHEME 1.

Selected established methods for chemical C‐formylation of phenols and the unprecedent biocatalytic C‐formylation of resorcinol. (A) Gattermann–Adams formylation of electron‐rich aromatic compounds using zinc cyanide, (B) base‐promoted Reimer–Tiemann formylation of phenols with chloroform, (C) Vilsmeyer‐Haack formylation of electron‐rich aromatics using N,N‐dimethylformamide and phosphorus oxychloride, (D) acyltransferase (ATase)‐catalyzed formylation of electron‐rich aromatic compounds.
Formylation/formyl transfer involving enzymes has in general been described to occur at nitrogen atoms but not at a carbon: beyond the biosynthetic pathways, such as the initiation of protein synthesis via N‐formylmethionine, mediated by methionyl‐tRNA formyltransferase [76], or in the biosynthesis of purine nucleotides by transformylases [77], only a few examples of nonnatural enzymatic N‐formylation have been described (Figure S40), including transformations catalyzed by Candida antarctica lipase [78], chitobiose deacetylase [79], and N‐formyltransferase [80]. Formaldehyde has been described as a substrate in a C–C‐formation reaction in the artificial formolase‐catalyzed carboligation of three molecules of formaldehyde to form dihydroxyacetone [81, 82].
Herein, we report an unprecedented biocatalytic C‐formylation of resorcinol derivatives, offering an alternative to chemical methods and expanding the catalytic repertoire of acyltransferases acting on phenolic substrates (Scheme 1D) [62, 63, 64, 83].
2. Results and Discussion
2.1. Search for Promiscuous Activity
As C‐formylation of phenols has not been described in metabolic pathways yet, we started to search for enzymes transferring acyl groups without the need for activation, for example, as SCoA derivative. Such an SCoA‐free activity has been described in the disproportionation of monoacetylphloroglucinol to diacetylphloroglucinol (DAPG) and phloroglucinol catalyzed by a multicomponent acyltransferase (ATase) consisting of three subunits (PhlA, PhlC, and PhlB) [84, 85], which was later exploited in acylation reactions [62, 63, 64, 83]. Previous studies have shown that production of a functional ATase requires expression of the complete PhlACB operon, although the catalytic activity is primarily attributed to the PhlC subunit, a member of the thiolase superfamily. Within this operon, the PhlA subunit shows structural similarity to hydroxymethylglutaryl‐CoA synthases and β‐oxoacyl–(acyl‐carrier‐protein) synthases, whereas PhlB resembles a Zn‐ribbon–domain OB‐fold (oligonucleotide/oligosaccharide‐binding) protein [86]. Consequently, the gene cluster of such an ATase (PhlACB gene cluster sequence of Pseudomonas protegens) was taken as a template for a BLAST search to identify homologous subunits in other organisms to set up an enzyme library potentially capable of catalyzing the formylation of phenolic substrates in an aqueous environment. A search of the NCBI database yielded over 100 acyltransferase sequences, from which seven were arbitrarily selected (Table 1). Each sequence originated from a different species of prokaryote. Average sequence identity to the template for the three subunits ranged from 33%—the lowest, found in the Thermofilum pendens enzyme—to 96%, observed in the enzyme from Pseudomonas piscis (Table S3). When just considering the transfer‐active subunit PhlC, sequence identity varied between 30% and 98% (Table 1). Notably, the PhlACB gene cluster from Chromobacterium sphagni, which shares 81% average sequence identity with the template, was included, as the activity of the DAPG biosynthetic cluster in the Chromobacterium genus was reported very recently [87]. The seven multimeric homologous enzymes and the template were successfully produced in Escherichia coli (Figure S3) and subsequently tested as cell‐free extract (CFE) preparation for their ability to catalyze the formylation of the model substrate resorcinol (1a) using phenyl formate (2a) as formyl donor at 5 mM substrate concentration of 1a and 10 equivalents of donor. Gratifying, four of the eight enzymes tested showed formylation activity (Table 1). In addition to PpATase, two Pseudomonas‐derived enzymes, PkATase and PtATase, demonstrated catalytic activity, while the CFE preparation with PpiATase (98% sequence identity for PhlC, but just 92% coverage) showed no detectable activity, which might be attributed to the missing of 28 residues at the N‐terminus of the PhlC‐subunit (Figure S33). CsATase also exhibited promising activity, which was particularly interesting as it displayed significantly lower expression levels compared to PpATaseCH (Figure S3). To enhance the expression level of CsATase, the expression construct was engineered by introducing linkers, prefixes, and suffixes between the PhlC and PhlB subunits in a comparable fashion as described for PpATaseCH (Figure S1). This modification resulted in clearly improved expression levels (Figure S4).
TABLE 1.
Initial test on the formylation of 1a using different ATases.
| |||
|---|---|---|---|
| Enzyme | Origin | PhlC Seq. Id. [%] a | Product formation b |
| PpATaseCH | Pseudomonas protegens | 100 | ++ |
| PtATase | Pseudomonas thivervalensis | 94 | + |
| PkATase | Pseudomonas kilonensis | 87 | + |
| PpiATase | Pseudomonas piscis | 98 | — |
| CsATase | Chromobacterium sphagni | 91 | ++ |
| BtATase | Brenneria tiliae | 73 | — |
| VbATase | Vibrio aerogenes | 63 | — |
| TpATase | Thermofilum pendens | 30 | — |
Sequence identity in comparison to the template PpATase for the subunit PhlC, which is the subunit bearing the catalytic site for acyltransfer.
++ means ≥50% product formation; +: 0–49%; ‐: below detection limit. Reactions were performed in 1.5 mL polypropylene tubes at 35°C, 900 rpm for 18 h, in 1 mL reaction volume, using 5 mM of resorcinol 1a, 50 mM of 2a, 60 mU/mL of CFE of ATases in KPi buffer (100 mM, pH 7.5).
2.2. Scope of Formyl Donors and Reaction Engineering
In the next step, the scope of formyl donors was investigated for the two best‐performing enzymes, CsATase and PpATaseCH, testing mixed anhydrides (2b‐2d) (Figure 1), amides (2e‐2f), and aliphatic esters (2g‐2k) (Figure S9). Among the tested donors, phenyl formate (2a) was the most effective one in the ATase‐catalyzed formylation of 1a (10 mM) (Figure 1). CsATase reached 89% conversion, outperforming here PpATaseCH (72%). Other donors, such as 2b–2d, resulted in lower conversions compared to ester 2a. Nevertheless, the mixed anhydride from pivalic and formic acid 2b was also accepted reasonably well by CsATase, leading to a conversion of 32% under the conditions used. One could expect that for the mixed anhydrides both acyl parts could be transformed, leading to a product mixture. This was indeed observed for acetic formic anhydride (2d) which led to both formylation as the main reaction and to a smaller extent acetylation (<2% conversion with a ratio between formyl:acetyl product 2:1).
FIGURE 1.

Conversions for accepted formyl donors for the formylation of 1a. Conversions are shown in blue for PpATaseCH and in cyan for CsATase. Reactions were performed in 1.5 mL polypropylene tubes at 35°C, 900 rpm for 18 h, in 1 mL reaction volume, using 10 mM of 1a, 50 mM of formyl donor, and 60 mU/mL of CFE of ATases (for specific activities see Table S10) in KPi buffer (100 mM, pH 7.5).
It is worth mentioning that the mixed anhydrides underwent very fast spontaneous hydrolysis in the aqueous environment, which is likely one reason for the limited product formation in these cases. The other formyl donors tested (2e‐2k) did not lead to detectable product formation. Consequently, phenyl formate (2a) was the formyl donor of choice for the further experiments. Notably, using 2a as donor, exclusively mono‐formylation of resorcinol at position C4 was observed, while, for example, with Reimer–Tiemann conditions formylation leads to products with the carbaldehyde moiety at C2 and C4 (C2:C4 ∼ 2:1) [88].
As the formyl donor 2a also undergoes spontaneous hydrolysis like the mixed anhydrides but slower, its spontaneous degradation was followed over time (Figure S8). The results indicated that in case the donor is added at the beginning of the reaction at 50 mM, almost 90% were hydrolyzed after 80 min. This suggests that either the reaction should be performed for a short time (ideally 1–2 h) or the donor may be added continuously. For the small‐scale experiments, we decided to adjust the reaction conditions in a way that the reaction time is only a few hours.
Additionally, we were curious whether product 3a would also serve as a substrate for the ATase potentially undergoing hydrolysis. This reverse hydrolysis reaction was investigated using CsATase and PpATaseCH at varying enzyme concentrations (Table S11). Indeed, 3a underwent slow enzyme‐catalyzed deformylation when tested at 10 mM, leading to around 2% deformylated product within 18 h. Fortunately, the formylation (83 nmol min−1 mg−1 CFE) proceeds approximately 900 times faster than the deformylation reaction (0.093 nmol min−1 mg−1 CFE). This again supports that a short reaction time is preferable for the formylation reaction. To maximize conversion in the formylation of 1a with 2a, various enzyme loadings and formyl donor concentrations were evaluated. Increasing the amount of enzyme CsATase led to almost complete conversion (99%) of 10 mM 1a within 1 h, whereas PpATaseCH never reached more than 82% (Figure 2A). Based on these results and prior optimization, 60 mU/mL was employed for subsequent reactions. Evaluating the impact of the concentration of the formyl donor 1a on the reaction outcome (Figure 2B), a concentration of 70 mM was selected as the most suitable for the lab‐scale experiments. Again, the CsATase was clearly superior to the PpATase, as CsATase allowed to reach completion, while the conversions with PpATase were limited to a maximum of 87%.
FIGURE 2.

Formylation of 1a using different quantities of acyltransferase (A) and various concentrations of 2a (B). Conversions are shown in blue for PpATaseCH and in cyan for CsATase. Reactions were performed in 1.5 mL polypropylene tubes at 35°C, 900 rpm for 1 h, in 1 mL reaction volume, using 10 mM of 1a, 30–100 mM of 2a (50 mM for A), 20–100 mU/mL (60 mU/mL for B) of CFE of ATase in KPi buffer (100 mM, pH 7.5). Standard deviations were calculated from duplicate measurements.
2.3. Substrate Scope
To tap the potential of substrates, a panel of phenolic compounds was evaluated using phenyl formate as the formyl donor and CsATase as the best biocatalyst. Substrates bearing two hydroxyl groups in 1,3‐position (resorcinol derivatives) were efficiently converted by CsATase (Scheme 2), whereas substrates bearing only one hydroxy group, like in guaiacol (1m) or phenol (1k), or having the hydroxy groups in 1,4‐position (1l) were not accepted (Figure S10). Substituents on resorcinol were accepted in positions 4 and 5, while position 2, as far as tested, was not accessible. For instance, the methyl group was accepted in position 4 (1b) as well as 5 (1c), whereby the latter led to higher conversion (92%) under the conditions tested. Also, chloro and methoxy groups were accepted as substituents (1d, 1e). Increasing the size of the alkyl substituent in position 4 showed that with increasing length of the substituent from ethyl (1f) over n‐propyl (1g) to n‐hexyl (1h), also the conversion went up, reaching 99% for 1h. Even a fused ring in position 4,5 was accepted (substrate 1i), although the conversion was moderate (21%). However, increasing this substrate part even further, like to a flavone derivative (1r) (Figure S10), led to nonaccepted substrates; the same is true for a carboxylic acid moiety in position 4 (1o) or its ester in position 5 (1p). For all the resorcinol substrates accepted (Scheme 2), exclusively mono‐formylation was observed in a regioselective fashion.
SCHEME 2.

Scope of formyl acceptors in the biocatalytic C‐formylation of resorcinol derivatives. Reaction time for analytical reactions is 18 h, for preparative transformations see scheme. For solubility reasons 10% v/v DMSO was used in case of 1b‐1i. Conversions were calculated based on calibration curves with the respective compounds and correspond also to HPLC yield due to a closed mass balance.
To demonstrate the transformations on a semi‐preparative scale, the reactions were run for resorcinol derivatives 1a–i using 100 mg of each substrate. Reaction progress was monitored over time, and each transformation was quenched upon conversion reaching a plateau under these conditions. The aldehydes 3a–i were purified and isolated in moderate‐to‐high yields (7–74%, Scheme 2) and characterized by NMR (see Supporting information). No side products were detected; the diminished isolated yields in selected cases are due to challenging product isolation as a result of the similar polarity of product and co‐product (phenol).
Considering 1,3,5‐trihydroxybenzene (phloroglucinol 1j) as substrate, mono‐, di‐ or tri‐formylation could be expected. Testing phloroglucinol (1j), indeed, di‐substitution was found giving 4j without any detectable tri‐substitution (Scheme 3). Monitoring the progress of the formylation of 1j over time revealed that the mono‐formylated intermediate 3j was only detected in the initial phase of the formylation (Figure 3). A recent review [89] indicated that getting selectively only the di‐formylated phloroglucinol (2,4,6‐trihydroxyisophthalaldehyde 4j) is challenging due to the strong deactivating effect of the formyl group on the aromatic ring [18].
SCHEME 3.

Biocatalytic di‐C‐formylation of phloroglucinol 1j and bioactive molecules having 4j as a precursor.
FIGURE 3.

Time course of the CsATase catalyzed formylation of 1j. The concentration of substrate 1j (solid line, °), mono‐formylated product 3j (solid lines, □), and di‐formylated product 4j (dashed lines, △) were determined by HPLC using calibration curves. Reactions were performed in 1.5 mL polypropylene tubes at 35°C, 900 rpm for 2 h, in 1 mL reaction volume, using 2 mM of 1j, 70 mM of 2a, 60 mU/mL of CFE of ATase in KPi buffer (100 mM, pH 7.5).
It is worth noting that 4j can be converted in a single step into the antimalarial robustadials A and B (Scheme 3) [90], and is a precursor in the synthesis of cancer chemopreventive euglobals [91], and antifouling sideroxylonals, which occur in plant leaves exhibiting significant antifeedant activity [92]. The latter is composed of two trihydroxyisophthalaldehyde molecules and has also shown notable antibacterial activity against Gram‐positive bacteria such as Staphylococcus aureus and Bacillus subtilis [93]. After some optimization, phloroglucinol 1j was efficiently converted to the di‐formylated product 4j with excellent conversion (>99%). Performing the di‐formylation of 1j on a semi‐preparative scale (100 mg) yielded 82 mg of 4j (57% isolated yield, for NMR see Supporting information). For comparison, chemical di‐formylation of 1j has been reported either with Vilsmeier–Haack reagent (3 equiv. each of POCl3 and DMF) in 40% yield [90] and with Gattermann–Adams in 1.5% yield [94], thus the biocatalytic version is an interesting alternative.
2.4. Structure Elucidation and Mechanism
The crystal structure of the newly identified acyltransferase from C. sphagni (CsATase) was determined by X‐ray crystallography at a resolution of 2.6 Å (Table S12). The structure was solved by molecular replacement involving automated and manual rebuilding (see Supporting information). CsATase is a multienzyme complex and consists of three individual subunits in multiple copies: PhlA, PhlB, and PhlC. The structure of the assembly is best described as a Phl(A2C2)2B4 heterododecamer (Figure 4A) similarly to the previously reported structure from PpATaseCH [86].
FIGURE 4.

(A) Structure of the heterododecamer of CsATase (PhlA = cyan, PhlB = magenta, PhlC = blue) (PDB 9SKH). (B) Structural overlay of the PhlC wild‐type CsATase (blue) and the PhlC‐CsATase C88S variant (PDB 9SKM) (light purple).
From the three subunits (PhlA, PhlB, and PhlC) it was expected that only PhlC is responsible for the formylation reaction, whereby a cysteine at position 88 (C88) in the PhlC subunit might be directly involved in formyl transfer. To test this assumption, C88 was exchanged for a serine by site‐selective mutagenesis. The variant was successfully expressed in a soluble form and crystallized. The structure of the C88S variant was solved at 1.8 Å resolution, whereby the structures of the C88S variant and the wild‐type aligned well with each other (Figure 4B), with an RMSD of 0.204 Å over 3397 residues. In a biocatalytic transformation test, the C88S variant did not show any formylation activity, confirming the essential catalytic function of C88 in the PhlC subunit.
As soaking experiments with substrates failed to yield well‐diffracting crystals, molecular docking experiments were performed to examine the binding mode and orientation of the substrate within the active site of the crystal structure of CsATase. Docking of the substrate into the structure resulted in poor substrate positioning, with the ligand being too distant from the catalytic Cys88. The reason for that was most likely that the crystal structure in the absence of a ligand captured the enzyme in an open conformation with a tryptophan (W211) displaced away from the active site, as observed in other studies [86]. Consequently, when simulating the closed conformation of W211, the binding poses observed were consistent with key mechanistic steps of a previously proposed reaction mechanism for acylation, based on quantum chemical calculations [95].
The formylation of resorcinol most likely consists of two half‐reactions: (i) the formylation of the enzyme by a formyl donor (first half‐reaction) and (ii) the transfer of the formyl group to the acceptor molecule, such as resorcinol (second half‐reaction). Separate experiments indicated that the formyl transfer occurs directly to the carbon of the resorcinol and not via O‐formylation followed by spontaneous rearrangement (see Supporting information). Docking of phenyl formate 2a placed the donor in a conformation, where the formyl group is oriented toward the region defined by His144, Phe148, and Gly384 enabling a nucleophilic attack by the thiol group of Cys88 residue on the carbonyl carbon of phenyl formate (Figure 5A, Scheme 4), leading to the formation of a covalent enzyme–substrate intermediate. Stabilization of the negative charge on the oxygen atom in this alkoxide intermediate may be facilitated by an oxyanion hole formed by residues Gly385 and Asp87. To dock acceptor molecules to the active site, the formyl group was manually inserted at the C88 residue. Substrates 1a (Figure 5B), 1h and 1i (Figure S39) were modeled into the active site using AutoDock Vina and Schrödinger Glide. The docking results obtained with AutoDock Vina corresponded well with the previously published crystal structure containing phloroglucinol (Figure S36). The phenolic hydroxyl group at C‐1 of 1a points to the region defined by His56 and His144 (Figure 5B), and the hydroxyl group at C‐3 to His347 and Tyr124. The observed orientation of the hydroxyl groups is consistent with the mechanism in which deprotonation at C‐1 and C‐3 facilitates activation of the aromatic ring for electrophilic attack, followed by a C─C bond formation between the C‐6 carbon of the substrate and the formyl group covalently bonded to Cys88. Mutagenesis of these key residues (C88, H144, Y124, H347) in the active site resulted in complete loss of activity (Table S10), confirming their essential contribution to the catalytic mechanism. The docking results also indicated that the substrate binding site can accommodate bulkier substrates such as 1i (Figure S39A) and 1h; for the latter, its alkyl chain points toward to outside of the active site (Figure S39B,C).
FIGURE 5.

(A) Crystal structure of CsATase PhlC with donor substrate phenyl formate modeled into the active site by simulating the closed conformation of residue W211. (B) Crystal structure with acceptor substrate resorcinol modeled into the active site by extending the formyl moiety manually and simulating the closed conformation of residue W211. The shown distances are displayed in Å.
SCHEME 4.

Plausible mechanism for the formyltransfer from phenyl formate to the active Cys88 of CsATase.
3. Conclusion
Formylation of aromatic compounds has not been described to be catalyzed by an enzyme before. By screening a library of multimeric three‐component acyltransferases, the acyltransferase originating from C. sphagni (CsATase) was identified allowing to formylate resorcinol 1a and derivatives as a promiscuous unprecedent activity with outstanding regioselectivity. Conversions up to 99% were reached (e.g., at 10 mM substrate concentration), and the products were isolated with up to 74% yield. Investigation of the substrate pattern indicated flexibility, especially for substitutions at positions 4 and 5. For resorcinol substrates, regioselective mono‐formylation was observed. In the case of 1,3,5‐trihydroxybenzene (phloroglucinol), the enzyme exhibited di‐formylation activity, giving an essential precursor for various bioactive compounds (e.g., robustadials, euglobals [91], sideroxylonals) at 99% conversion.
Structure elucidation by X‐ray crystallography of the wild‐type enzyme and the cysteine variant followed by docking provided insight into substrate binding and processing. Mutational analysis demonstrated that the cysteine residue at position 88 (C88) in the active site of PhlC is essential for catalysis. The same is true for H144, Y124, H347.
This study opens new avenues to develop unprecedented C─C bond forming reactions and paves the way for further studies to exploit enzymes for the C‐formylation of aromatic compounds.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Supporting File 1: The authors have cited additional references within the Supporting Information [1–15].
Supporting File 2: anie71292‐sup‐0002‐Data.zip.
Acknowledgements
This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska‐Curie grant agreement no. 101073065. We gratefully acknowledge access to the Deutsches Elektronen‐Synchrotron (DESY), Hamburg, and we also thank the Crystallization Facility of the Max Planck Institute for Multidisciplinary Sciences for their contributions. We thank Markus Köck for performing the high‐resolution mass spectrometry (HR‐MS) and Klaus Zangger/Bernd Werner for NMR measurements. We also thank Fabian Rabe von Pappenheim for his assistance in the analysis and validation of the crystal structures. J. M. acknowledges support from the Erasmus+ Programme of the European Union for funding a research stay at University of Graz. The University of Graz and the Field of Excellence BioHealth at the University of Graz are acknowledged for financial support.
Open Access funding provided by Universitat Graz/KEMÖ.
Contributor Information
Kai Tittmann, Email: Kai.Tittmann@biologie.uni-goettingen.de.
Wolfgang Kroutil, Email: wolfgang.kroutil@uni-graz.at.
Data Availability Statement
The data that support the findings of this study are available in the supplementary material of this article.
References
- 1. Smith M. B. and March J. Oxidations and Reductions (John Wiley & Sons, Inc., Hoboken, New Jersey: 2006), 10.1002/0470084960. [DOI] [Google Scholar]
- 2. Verter H. S., Oxidation of aldehydes and ketones in The Carbonyl Group (Ed.: Zabicky J.), John Wiley & Sons Ltd., 1970, pp. 71–156. [Google Scholar]
- 3. Li J. J., Tishchenko Reaction in Name Reactions: A Collection of Detailed Reaction Mechanisms (Springer‐Verlag Berlin Heidelberg, Dordrecht Heidelberg London New York: 2003), 10.1007/978-3-662-05336-2. [DOI] [Google Scholar]
- 4. Zhu J. and Yin G., “Catalytic Transformation of the Furfural Platform Into Bifunctionalized Monomers for Polymer Synthesis,” ACS Catalysis 11 (2021): 10058–10083, 10.1021/acscatal.1c01989. [DOI] [Google Scholar]
- 5. Liu X. X., Hu Z. R., Duan M. F., and Cheng D. J., “Research Progress on Organocatalytic Asymmetric Synthesis of Atropisomeric Aldehydes,” Advanced Synthesis & Catalysis 367 (2025): e202401553, 10.1002/adsc.202401553. [DOI] [Google Scholar]
- 6. Kantlehner W., “New Methods for the Preparation of Aromatic Aldehydes,” European Journal of Organic Chemistry 2003 (2003): 2530–2546, 10.1002/ejoc.200200653. [DOI] [Google Scholar]
- 7. Kherudkar A., Bhattacharjee A., Nawkhare A., Mukherjee S., Pramanick S., and Laha J. K., “Recent Advances on Direct Formylation Reactions,” Chemical Record 23 (2023): e202300063, 10.1002/tcr.202300063. [DOI] [PubMed] [Google Scholar]
- 8. Gattermann L. and Berchelmann W., “Synthese Aromatischer Oxyaldehyde,” Berichte der Deutschen Chemischen Gesellschaft 31 (1898): 1765–1769, 10.1002/cber.18980310281. [DOI] [Google Scholar]
- 9. Truce W. E., “The Gattermann Synthesis of Aldehydes,” Organic Reactions 9 (1957): 37–72. [Google Scholar]
- 10. Wang Z. Gattermann Aldehyde Synthesis (John Wiley & Sons, Hoboken, New Jersey: 2009). [Google Scholar]
- 11. Adams R. and Levine I., “Simplification of the Gattermann Synthesis of Hydroxy Aldehydes,” Journal of the American Chemical Society 45 (1923): 2373–2377, 10.1021/ja01663a020. [DOI] [Google Scholar]
- 12. Reimer K. and Tiemann F., “Ueber die Einwirkung von Chloroform auf Alkalische Phenolate,” Berichte der Deutschen Chemischen Gesellschaft 9 (1876): 824–828, 10.1002/cber.187600901247. [DOI] [Google Scholar]
- 13. Wynberg H. and Meijer E. W., “The Reimer‐Tiemann Reaction,” Organic Chemistry (1982): 1–36. [Google Scholar]
- 14. Wynberg H., “The Reimer‐Tiemann Reaction,” Chemical Reviews 60 (1960): 169–184, 10.1021/cr60204a003. [DOI] [Google Scholar]
- 15. Ding S. and Jiao N., “ N,N‐Dimethylformamide: A Multipurpose Building Block,” Angewandte Chemie, International Edition 51 (2012): 9226–9237, 10.1002/anie.201200859. [DOI] [PubMed] [Google Scholar]
- 16. Mendelson W. L. and Hayden S., “Preparation of 2,4‐Dihydroxybenzaldehyde by the Vilsmeier‐Haack Reaction,” Synthetic Communications 26 (1996): 603–610, 10.1080/00397919608003654. [DOI] [Google Scholar]
- 17. Vilsmeier A. and Haack A., “Über die Einwirkung von Halogenphosphor auf Alkyl‐formanilide. Eine Neue Methode zur Darstellung Sekundärer und Tertiärer p‐Alkylamino‐benzaldehyde,” Berichte der Deutschen Chemischen Gesellschaft 60 (1927): 119–122. [Google Scholar]
- 18. Lindoy L. F., Meehan G. V., and Svenstrup N., “Mono‐ and Diformylation of 4‐Substituted Phenols: A New Application of the Duff Reaction,” Synthesis 1998 (1998): 1029–1032, 10.1055/s-1998-2110. [DOI] [Google Scholar]
- 19. Grimblat N., Sarotti A. M., Kaufman T. S., and Simonetti S. O., “A Theoretical Study of the Duff Reaction: Insights Into Its Selectivity,” Organic & Biomolecular Chemistry 14 (2016): 10496–10501, 10.1039/C6OB01887D. [DOI] [PubMed] [Google Scholar]
- 20. Casiraghi G., Casnati G., Puglia G., Sartori G., and Terenghi G., “Selective Reactions Between Phenols and Formaldehyde. A Novel Route to Salicylaldehydes,” Journal of the Chemical Society, Perkin Transactions (1980): 1862, 10.1039/p19800001862. [DOI] [Google Scholar]
- 21. Klumpp D. A., Deb T., and Littich R., “Ortho‐Formylation of Phenols: The Casnati–Skattebøl Reaction in the Synthesis of Biologically Active Substances,” Synthesis 57 (2025): 1651–1659, 10.1055/a-2520-0095. [DOI] [Google Scholar]
- 22. Olah G. A., Ohannesian L., and Arvanaghi M., “Formylating Agents,” Chemical Reviews 87 (1987): 671–686, 10.1021/cr00080a001. [DOI] [Google Scholar]
- 23. Olah G. A. and Kuhn S. J. Friedel Crafts and Related Reactions, Vol. III (Interscience Publishers, New York: 1964). [Google Scholar]
- 24. Groß H., Farkas I., and Bognár R., “Dichlormethyl‐methylether Als Reagens für die Organische Synthese‐ und Kohlenhydratchemie,” Zeitschrift für Chemie 18 (1978): 201–210. [Google Scholar]
- 25. Rieche A., Gross H., and Höft E., “Über α‐Halogenäther, IV. Synthesen Aromatischer Aldehyde mit Dichlormethyl‐Alkyläthern,” Chemische Berichte 93 (1960): 88–94, 10.1002/cber.19600930115. [DOI] [Google Scholar]
- 26. Bagno A., Kantlehner W., Scherr O., Vetter J., and Ziegler G., “New Formylating Agents − Preparative Procedures and Mechanistic Investigations,” European Journal of Organic Chemistry 2001 (2001): 2947–2954, 10.1002/1099-0690(200108)2001:15<2947::AID-EJOC2947>3.0.CO;2-R. [DOI] [Google Scholar]
- 27. Bornscheuer U. T., “Biocatalysis: Successfully Crossing Boundaries,” Angewandte Chemie, International Edition 55 (2016): 4372–4373, 10.1002/anie.201510042. [DOI] [PubMed] [Google Scholar]
- 28. Winkler C. K., Schrittwieser J. H., and Kroutil W., “Power of Biocatalysis for Organic Synthesis,” ACS Central Science 7 (2021): 55–71, 10.1021/acscentsci.0c01496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. France S. P., Lewis R. D., and Martinez C. A., “The Evolving Nature of Biocatalysis in Pharmaceutical Research and Development,” Journal of the American Chemical Society Au 3 (2023): 715–735, 10.1021/jacsau.2c00712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Romero E. O., Saucedo A. T., Hernández‐Meléndez J. R., Yang D., Chakrabarty S., and Narayan A. R. H., “Enabling Broader Adoption of Biocatalysis in Organic Chemistry,” Journal of the American Chemical Society Au 3 (2023): 2073–2085, 10.1021/jacsau.3c00263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Kissman E. N., Sosa M. B., Millar D. C., Koleski E. J., Thevasundaram K., and Chang M. C. Y., “Expanding Chemistry Through In Vitro and In Vivo Biocatalysis,” Nature 631 (2024): 37–48, 10.1038/s41586-024-07506-w. [DOI] [PubMed] [Google Scholar]
- 32. Grandi E., Feyza Özgen F., Schmidt S., and Poelarends G. J., “Enzymatic Oxy‐ and Amino‐Functionalization in Biocatalytic Cascade Synthesis: Recent Advances and Future Perspectives,” Angewandte Chemie, International Edition 62 (2023): e202309012, 10.1002/anie.202309012. [DOI] [PubMed] [Google Scholar]
- 33. Buller R., Lutz S., Kazlauskas R. J., Snajdrova R., Moore J. C., and Bornscheuer U. T., “From Nature to Industry: Harnessing Enzymes for Biocatalysis,” Science 382 (2023): eadh8615, 10.1126/science.adh8615. [DOI] [PubMed] [Google Scholar]
- 34. Reed J. H. and Seebeck F. P., “Reagent Engineering for Group Transfer Biocatalysis,” Angewandte Chemie, International Edition 63 (2024): e202311159, 10.1002/anie.202311159. [DOI] [PubMed] [Google Scholar]
- 35. Bayer T., Wu S., Snajdrova R., Baldenius K., and Bornscheuer U. T., “An Update: Enzymatic Synthesis for Industrial Applications,” Angewandte Chemie, International Edition 64 (2025): e202505976, 10.1002/anie.202505976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Li Y., Fan Y., Yao P., Wu Q., and Zhu D., “Formaldehyde‐Enabled Enzymatic Hydroxymethylation for the Synthesis of High Value‐Added Multifunctional Compounds,” ChemCatChem 17 (2025): e202402005, 10.1002/cctc.202402005. [DOI] [Google Scholar]
- 37. Reisenbauer J. C., Sicinski K. M., and Arnold F. H., “Catalyzing the Future: Recent Advances in Chemical Synthesis Using Enzymes,” Current Opinion in Chemical Biology 83 (2024): 102536, 10.1016/j.cbpa.2024.102536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Kumar V., Turnbull W. B., and Kumar A., “Review on Recent Developments in Biocatalysts for Friedel–Crafts Reactions,” ACS Catalysis 12 (2022): 10742–10763, 10.1021/acscatal.2c01134. [DOI] [Google Scholar]
- 39. Zetzsche L. E. and Narayan A. R. H., “Broadening the Scope of Biocatalytic C─C Bond Formation,” Nature Reviews Chemistry 4 (2020): 334–346, 10.1038/s41570-020-0191-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Schmidt N. G., Eger E., and Kroutil W., “Building Bridges: Biocatalytic C─C‐Bond Formation Toward Multifunctional Products,” ACS Catalysis 6 (2016): 4286–4311, 10.1021/acscatal.6b00758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Miao Y., Rahimi M., Geertsema E. M., and Poelarends G. J., “Recent Developments in Enzyme Promiscuity for Carbon–Carbon Bond‐Forming Reactions,” Current Opinion in Chemical Biology 25 (2015): 115–123, 10.1016/j.cbpa.2014.12.020. [DOI] [PubMed] [Google Scholar]
- 42. Müller M., “Recent Developments in Enzymatic Asymmetric C‐C Bond Formation,” Advanced Synthesis & Catalysis 354 (2012): 3161–3174, 10.1002/adsc.201100655. [DOI] [Google Scholar]
- 43. Resch V., Schrittwieser J. H., Siirola E., and Kroutil W., “Novel Carbon–carbon Bond Formations for Biocatalysis,” Current Opinion in Biotechnology 22 (2011): 793–799, 10.1016/j.copbio.2011.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Lan Y., Zhang C., Tang C., et al., “Semirational Protein Engineering of a Decarboxylative Aldolase for the Regiodivergent and Stereodivergent Synthesis of Cyclic Imino Acids,” Angewandte Chemie, International Edition 64 (2025): e202500080, 10.1002/anie.202500080. [DOI] [PubMed] [Google Scholar]
- 45. Bruffy S. K., Meza A., Soler J., et al., “Biocatalytic Asymmetric Aldol Addition Into Unactivated Ketones,” Nature Chemistry 16 (2024): 2076–2083, 10.1038/s41557-024-01647-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Fansher D. J. and Palmer D. R. J., “A Type 1 Aldolase, NahE, Catalyzes a Stereoselective Nitro‐Michael Reaction: Synthesis of β‐Aryl‐γ‐nitrobutyric Acids,” Angewandte Chemie, International Edition 62 (2023): e202214539, 10.1002/anie.202214539. [DOI] [PubMed] [Google Scholar]
- 47. Lee S.‐H., Yeom S.‐J., Kim S.‐E., and Oh D.‐K., “Development of Aldolase‐based Catalysts for the Synthesis of Organic Chemicals,” Trends in Biotechnology 40 (2022): 306–319, 10.1016/j.tibtech.2021.08.001. [DOI] [PubMed] [Google Scholar]
- 48. Windle C. L., Müller M., Nelson A., and Berry A., “Engineering Aldolases as Biocatalysts,” Current Opinion in Chemical Biology 19 (2014): 25–33, 10.1016/j.cbpa.2013.12.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Brovetto M., Gamenara D., Saenz Méndez P., and Seoane G. A., “C−C Bond‐Forming Lyases in Organic Synthesis,” Chemical Reviews 111 (2011): 4346–4403, 10.1021/cr100299p. [DOI] [PubMed] [Google Scholar]
- 50. Clapés P., Fessner W. D., Sprenger G. A., and Samland A. K., “Recent Progress in Stereoselective Synthesis With Aldolases,” Current Opinion in Chemical Biology 14 (2010): 154–167, 10.1016/j.cbpa.2009.11.029. [DOI] [PubMed] [Google Scholar]
- 51. Machajewski T. D. and Wong C.‐H., “The Catalytic Asymmetric Aldol Reaction,” Angewandte Chemie, International Edition 39 (2000): 1352–1375, 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
- 52. Sehl T., Hailes H. C., Ward J. M., et al., “Two Steps in One Pot: Enzyme Cascade for the Synthesis of Nor(pseudo)Ephedrine From Inexpensive Starting Materials,” Angewandte Chemie, International Edition 52 (2013): 6772–6775, 10.1002/anie.201300718. [DOI] [PubMed] [Google Scholar]
- 53. Hailes H. C., Rother D., Müller M., Westphal R., Ward J. M., and Pleiss J., “Engineering Stereoselectivity of ThDP‐Dependent Enzymes,” FEBS Journal 280 (2013): 6374–6394, 10.1111/febs.12496. [DOI] [PubMed] [Google Scholar]
- 54. Dobiašová H., Jurkaš V., Both P., and Winkler M., “Recent Progress in the Synthesis of α‐Hydroxy Carbonyl Compounds With ThDP‐Dependent Carboligases,” ChemCatChem 16 (2024): e202301707, 10.1002/cctc.202301707. [DOI] [Google Scholar]
- 55. Bjarnesen D., Lanza L., Presini F., Giovannini P. P., and Müller M., “Diversity of ThDP‐Dependent Enzymes Forming Chiral Tertiary Alcohols,” ChemBioChem 26 (2025): e202500200, 10.1002/cbic.202500200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Effenberger F., Förster S., and Wajant H., “Hydroxynitrile Lyases in Stereoselective Catalysis,” Current Opinion in Biotechnology 11 (2000): 532–539, 10.1016/S0958-1669(00)00141-5. [DOI] [PubMed] [Google Scholar]
- 57. Priya B. V. and Padhi S. K., “Hydroxynitrile Lyase Discovery, Engineering, and Promiscuity Towards Asymmetric Synthesis: Recent Progress,” European Journal of Organic Chemistry 26 (2023): e202300776, 10.1002/ejoc.202300776. [DOI] [Google Scholar]
- 58. Bracco P., Busch H., von Langermann J., and Hanefeld U., “Enantioselective Synthesis of Cyanohydrins Catalysed by Hydroxynitrile Lyases—A Review,” Organic & Biomolecular Chemistry 14 (2016): 6375–6389, 10.1039/C6OB00934D. [DOI] [PubMed] [Google Scholar]
- 59. Stecher H., Tengg M., Ueberbacher B. J., et al., “Biocatalytic Friedel–Crafts Alkylation Using Non‐Natural Cofactors,” Angewandte Chemie, International Edition 48 (2009): 9546–9548, 10.1002/anie.200905095. [DOI] [PubMed] [Google Scholar]
- 60. Tanner M. E., “Mechanistic Studies on the Indole Prenyltransferases,” Natural Product Reports 32 (2015): 88–101, 10.1039/C4NP00099D. [DOI] [PubMed] [Google Scholar]
- 61. Heckmann C. M., Heyes D. J., Pabst M., Otten E., Scrutton N. S., and Paul C. E., “Asymmetric Enantio‐Complementary Synthesis of Thioethers via Ene‐Reductase‐Catalyzed C─C Bond Formation,” Journal of the American Chemical Society 147 (2025): 18618–18625, 10.1021/jacs.5c00761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Schmidt N. G., Pavkov‐Keller T., Richter N., Wiltschi B., Gruber K., and Kroutil W., “Biocatalytic Friedel–Crafts Acylation and Fries Reaction,” Angewandte Chemie, International Edition 56 (2017): 7615–7619, 10.1002/anie.201703270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Żądło‐Dobrowolska A., Schmidt N. G., and Kroutil W., “Thioesters as Acyl Donors in Biocatalytic Friedel‐Crafts‐type Acylation Catalyzed by Acyltransferase From Pseudomonas Protegens ,” ChemCatChem 11 (2019): 1064–1068, 10.1002/cctc.201801856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Schmidt N. G. and Kroutil W., “Acyl Donors and Additives for the Biocatalytic Friedel–Crafts Acylation,” European Journal of Organic Chemistry 2017 (2017): 5865–5871, 10.1002/ejoc.201701079. [DOI] [Google Scholar]
- 65. Kozlowski M. C., “Oxidative Coupling in Complexity Building Transforms,” Accounts of Chemical Research 50 (2017): 638–643, 10.1021/acs.accounts.6b00637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Guengerich F. P. and Yoshimoto F. K., “Formation and Cleavage of C─C Bonds by Enzymatic Oxidation–Reduction Reactions,” Chemical Reviews 118 (2018): 6573–6655, 10.1021/acs.chemrev.8b00031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Michael C. and Chang W.‐C., “A Survey of C─C Bond Formation Strategies and Mechanism Deployed by Iron‐containing Enzymes in Natural Products,” Tetrahedron 161 (2024): 134084, 10.1016/j.tet.2024.134084. [DOI] [Google Scholar]
- 68. Hüttel W. and Müller M., “Regio‐ and Stereoselective Intermolecular Phenol Coupling Enzymes in Secondary Metabolite Biosynthesis,” Natural Product Reports 38 (2021): 1011–1043, 10.1039/D0NP00010H. [DOI] [PubMed] [Google Scholar]
- 69. Christianson D. W., “Structural and Chemical Biology of Terpenoid Cyclases,” Chemical Reviews 117 (2017): 11570–11648, 10.1021/acs.chemrev.7b00287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Klas K., Tsukamoto S., Sherman D. H., and Williams R. M., “Natural Diels–Alderases: Elusive and Irresistible,” Journal of Organic Chemistry 80 (2015): 11672–11685, 10.1021/acs.joc.5b01951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Coelho P. S., Brustad E. M., Kannan A., and Arnold F. H., “Olefin Cyclopropanation via Carbene Transfer Catalyzed by Engineered Cytochrome P450 Enzymes,” Science 339 (2013): 307–310, 10.1126/science.1231434. [DOI] [PubMed] [Google Scholar]
- 72. Porter N. J., Danelius E., Gonen T., and Arnold F. H., “Biocatalytic Carbene Transfer Using Diazirines,” Journal of the American Chemical Society 144 (2022): 8892–8896, 10.1021/jacs.2c02723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Chen K. and Arnold F. H., “Engineering Cytochrome P450s for Enantioselective Cyclopropenation of Internal Alkynes,” Journal of the American Chemical Society 142 (2020): 6891–6895, 10.1021/jacs.0c01313. [DOI] [PubMed] [Google Scholar]
- 74. Nam D., Steck V., Potenzino R. J., and Fasan R., “A Diverse Library of Chiral Cyclopropane Scaffolds via Chemoenzymatic Assembly and Diversification of Cyclopropyl Ketones,” Journal of the American Chemical Society 143 (2021): 2221–2231, 10.1021/jacs.0c09504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Zhang R. K., Chen K., Huang X., Wohlschlager L., Renata H., and Arnold F. H., “Enzymatic Assembly of Carbon–carbon Bonds via Iron‐Catalysed sp3 C–H Functionalization,” Nature 565 (2019): 67–72, 10.1038/s41586-018-0808-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Kozak M., “Comparison of Initiation of Protein Synthesis in Procaryotes, Eucaryotes, and Organelles,” Microbiological Reviews 47 (1983): 1–45, 10.1128/mr.47.1.1-45.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Thoden J. B., Firestine S., Nixon A., Benkovic S. J., and Holden H. M., “Molecular Structure of Escherichia coli PurT‐Encoded Glycinamide Ribonucleotide Transformylase,” Biochemistry 39 (2000): 8791–8802, 10.1021/bi000926j. [DOI] [PubMed] [Google Scholar]
- 78. Patre R. E., Mal S., Nilkanth P. R., et al., “First Report on Bio‐catalytic N‐formylation of Amines Using Ethyl Formate,” Chemical Communications 53 (2017): 2382–2385, 10.1039/C6CC07679C. [DOI] [PubMed] [Google Scholar]
- 79. Hu Z. X., Li S. R., Xia Q. J., et al., “Enzymatic Synthesis of N‐formylated Sialosides via a Five‐enzyme Cascade,” Organic & Biomolecular Chemistry 22 (2024): 7485–7491, 10.1039/D4OB00874J. [DOI] [PubMed] [Google Scholar]
- 80. Heisdorf C. J., Griffiths W. A., Thoden J. B., and Holden H. M., “Investigation of the Enzymes Required for the Biosynthesis of an Unusual Formylated Sugar in the Emerging Human Pathogen Helicobacter canadensis ,” Protein Science 30 (2021): 2144–2160, 10.1002/pro.4169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Cai T., Sun H., Qiao J., et al., “Cell‐free Chemoenzymatic Starch Synthesis From Carbon Dioxide,” Science 373 (2021): 1523–1527, 10.1126/science.abh4049. [DOI] [PubMed] [Google Scholar]
- 82. Li T., Tan Z., Tang Z., et al., “One‐pot Chemoenzymatic Synthesis of Glycolic Acid From Formaldehyde,” Green Chemistry 24 (2022): 5064–5069, 10.1039/D2GC00688J. [DOI] [Google Scholar]
- 83. Żądło‐Dobrowolska A., Schmidt N. G., and Kroutil W., “Promiscuous Activity of C‐acyltransferase From Pseudomonas Protegens: Synthesis of Acetanilides in Aqueous Buffer,” Chemical Communications 54 (2018): 3387–3390, 10.1039/C8CC00290H. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Hayashi A., Saitou H., Mori T., Matano I., Sugisaki H., and Maruyama K., “Molecular and Catalytic Properties of Monoacetylphloroglucinol Acetyltransferase From Pseudomonas sp. YGJ3. YGJ76,” Bioscience Biotechnology and Biochemistry 76 (2012): 559–566, 10.1271/bbb.110860. [DOI] [PubMed] [Google Scholar]
- 85. Yang F. and Cao Y., “Biosynthesis of Phloroglucinol Compounds in Microorganisms—Review,” Applied Microbiology and Biotechnology 93 (2012): 487–495, 10.1007/s00253-011-3712-6. [DOI] [PubMed] [Google Scholar]
- 86. Pavkov‐Keller T., Schmidt N. G., Żądło‐Dobrowolska A., Kroutil W., and Gruber K., “Structure and Catalytic Mechanism of a Bacterial Friedel–Crafts Acylase,” ChemBioChem 20 (2019): 88–95, 10.1002/cbic.201800462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Johnson E. T., Bowman M. J., Gomes R. P., Carneiro L. C., and Dunlap C. A., “Identification of 2,4‐diacetylphloroglucinol Production in the Genus Chromobacterium ,” Scientific Reports 13 (2023): 14292, 10.1038/s41598-023-41277-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Komiyama M. and Hirai H., “Selective Syntheses Using Cyclodextrin as Catalyst. 1. Control of Orientation in the Attack of Dichlorocarbene at Phenolates,” Journal of the American Chemical Society 105 (1983): 2018–2021, 10.1021/ja00345a058. [DOI] [Google Scholar]
- 89. Bashir M., Saifullah M., Riaz M., et al., “Schiff Bases Derived From Phloroglucinol Carbonyl Variants and Their Applications‐A Review,” Inorganic Chemistry Communications 152 (2023): 110690, 10.1016/j.inoche.2023.110690. [DOI] [Google Scholar]
- 90. Bharate S. B. and Singh I. P., “A Two‐step Biomimetic Synthesis of Antimalarial Robustadials A and B,” Tetrahedron Letters 47 (2006): 7021–7024, 10.1016/j.tetlet.2006.07.113. [DOI] [Google Scholar]
- 91. Faqueti L. G., Petry C. M., Meyre‐Silva C., et al., “Euglobal‐Like Compounds From the Genus Eugenia,” Natural Product Research 27 (2013): 28–31, 10.1080/14786419.2012.656113. [DOI] [PubMed] [Google Scholar]
- 92. McLean S., Brandon S., Davies N. W., Foley W. J., and Muller H. K., “Jensenone: Biological Reactivity of a Marsupial Antifeedant From Eucalyptus,” Journal of Chemical Ecology 30 (2004): 19–36, 10.1023/B:JOEC.0000013180.46747.07. [DOI] [PubMed] [Google Scholar]
- 93. Sidana J., Rohilla R. K., Roy N., Barrow R. A., Foley W. J., and Singh I. P., “Antibacterial Sideroxylonals and Loxophlebal A From Eucalyptus Loxophleba Foliage,” Fitoterapia 81 (2010): 878–883, 10.1016/j.fitote.2010.05.016. [DOI] [PubMed] [Google Scholar]
- 94. Gruber W., “Dialdehyde Des Phloroglucins und Seiner Homologen,” Berichte der Deutschen Chemischen Gesellschaft (A and B Series) 75 (1942): 29–33, 10.1002/cber.19420750104. [DOI] [Google Scholar]
- 95. Sheng X., Kazemi M., Żądło‐Dobrowolska A., Kroutil W., and Himo F., “Mechanism of Biocatalytic Friedel–Crafts Acylation by Acyltransferase From Pseudomonas Protegens,” ACS Catalysis 10 (2020): 570–577, 10.1021/acscatal.9b04208. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting File 1: The authors have cited additional references within the Supporting Information [1–15].
Supporting File 2: anie71292‐sup‐0002‐Data.zip.
Data Availability Statement
The data that support the findings of this study are available in the supplementary material of this article.
